“Receiving FDA clearance is a huge, pinnacle moment in our journey at MFB Fertility,” said Amy Beckley, MFB Fertility’s founder and CEO.
BOULDER, Colo. (PRWEB) March 11, 2020
Proov, a Boulder-based medical company created to empower women to know more about their reproductive health, today announces the FDA clearance of its at-home PdG - the urine metabolite of progesterone - test, marking the first-ever FDA-cleared product that allows for ovulation confirmation at home.
The announcement of its FDA clearance comes on the heels of additional momentum from the team, including a recent $50,000 grant from the Air Force to support military couples who are trying to conceive.
Proov’s test strips measure the presence of PdG - a urine metabolite of progesterone. Progesterone is the hormone released by the ovary after ovulation.Tracking levels of PdG after suspected ovulation can confirm that ovulation has successfully occurred. Problems with ovulation are the leading cause of infertility in women, so checking for healthy ovulation is critical when it comes to trying to conceive.
“Receiving FDA clearance is a huge, pinnacle moment in our journey at MFB Fertility,” said Amy Beckley, MFB Fertility’s founder and CEO. “We created Proov as a means to put the power and knowledge of reproductive health into the hands of women. I myself experienced years of struggling to conceive, multiple miscarriages and a feeling of general lacking within the fertility industry so I decided to leverage my doctorate in pharmacology and expertise in hormone signaling to do something about it which is how Proov ultimately came to be.”
Over 7 million couples suffer with infertility each year and the issues that Proov helps identify can help more than 40 percent of those couples. Proov test strips provide critical information about successful ovulation - information that can change the game for so many couples. If Proov results indicate a lack of ovulation or suboptimal ovulation, the fix can be as simple as lifestyle and diet changes or supplements and medications - solutions that are way less invasive and expensive that IVF. Regardless of results, Proov enables more informed conversations with doctors, helping women get treatment faster and ultimately closer to their desired outcomes.
From here, Proov plans to officially launch their mobile app this Spring. The software integration will help women to collect data on the hormones involved in ovulation to help get them closer to actionable answers. Additionally, the team will continue to build out its product pipeline, which includes products aimed at further addressing needs of women trying to conceive as well as expand to help women dealing with perimenopause.
To learn more about Proov®, visit proovtest.com and to learn more about PdG and the benefits of tracking it, visit https://proovtest.com/pages/faq.
About MFB Fertility, Inc.
MFB Fertility, Inc. developed Proov®, an at-home PdG test that measures the presence of progesterone metabolite PdG in urine to help a woman confirm that she has ovulated successfully. Originally co-founded in Boulder, Colo. by two women who both struggled to conceive, MFB Fertility was created to empower women to know more about their menstrual cycles, ovulation health, and PdG levels. Don't just predict ovulation, Proov it! For more information, please visit https://proovtest.com/.